Dr. Paul Lockman earned his B.S. in Nursing from West Texas A&M University, after which he practiced in intensive care, clinical toxicology, and emergency medicine, before earning his Ph.D. (Pharmaceutical Sciences) at Texas Tech University Health Sciences Center.

Dr. Paul Lockman was an Associate Professor and Associate Dean for Outcomes Assessment and Accreditation at Texas Tech University before transitioning to West Virginia University. Currently, Dr. Lockman is the Douglas Glover Endowed Chair of Basic Pharmaceutical Sciences at West Virginia University School of Pharmacy.

He also serves as the Associate Director for Translational Research at the Mary Babb Randolph Cancer Center.

Dr. Lockman’s primary research focus is on understanding why chemotherapy has limited distribution, and ultimately fails in brain metastases of breast cancer.

He is also working as Principal Investigator of Tumor Microenvironment (TME)COBRE, West Virginia.

Paul Lockman, PhD | School of Medicine | West Virginia University (wvu.edu)